{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-006236","form_type":"8-K","ticker":"TPB","cik":"0001290677","company_name":"Turning Point Brands, Inc.","filed_at":"2026-03-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.730987+00:00","generated_at":"2026-05-15T22:33:25.972267+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Turning Point Brands Q4 net sales up 29% to $121M; Modern Oral surges 266%","bullets":["Q4 net sales $121.0M (+29.2% YoY); net income $8.2M (+239.8%); adjusted EBITDA $30.0M (+14.4%).","Modern Oral net sales $41.3M in Q4 (+265.5% YoY); now 34% of total net sales.","FY 2025 net sales $463.1M (+28.4%); adjusted EBITDA $119.5M (+14.4%); diluted EPS $3.11 vs $2.14.","FY 2026 guidance: Modern Oral net revenue $180-$190M; Q1 2026 adj. EBITDA expected $24-$27M.","Stoker's segment Q4 net sales $81.0M (+69.5%); Zig-Zag segment $40.0M (-12.8%)."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-006236","json":"https://secwatch.observer/filing/0001437749-26-006236.json","markdown":"https://secwatch.observer/filing/0001437749-26-006236.md","text":"https://secwatch.observer/filing/0001437749-26-006236.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1290677/000143774926006236/0001437749-26-006236-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1290677/000143774926006236/tpb20260205_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T22:33:25.972267+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}